… in animal models of PD, while drugs found to be ineffective in experimental models, or …
primate (NHP) will be the focus of the current article (Table 1). We will, however, start this review …

… of PD, the parkinsonian non-human primate, which has high … On each of these scales, the
higher the score, the greater the … parkinsonism, dyskinesia, and PLB scores are presented as …

… The parkinsonian disability rating scale is presented in Table … From the analysis of the
PLBs, we also observed that … conducted in this small primate. These additions to the existing …

… To do so, we used the evidence-based medicine reviews … lesioned marmoset and identified
articles reporting the effects of drugs that … For the treatment of dyskinesia, we suggest that the …

… in both PD and experimental parkinsonism in non-human primates, … Our stereological analysis
did not find any changes in 5-HT+ … Finally, we found no statistical correlation between the …

… dyskinesia score at any time point is 12. In A, data are presented as the median; in B, data are
presented … striatal dopamine in human and non-human primate (Riederer and Laux 2011), …

… Scale (UDysRS) is considered superior to other scales for … Although early introduction of
dopamine agonists may be … Topiramate was shown in rat and non-human primate models to …

… to reduce dyskinesia in non-human primates with established LID [… A post hoc analysis of
this study showed that compared to … scales, including the commonest used in phase III RCTs of …

… presentation was repeated for each participant on each session). Analysis was performed with
the FSL Expert Analysis … We found that dyskinetic PD patients had reduced JNP thresholds…

… PD is envisioned today, review available PD NHP models, … seems to emerge from the
analysis of genes nominated by … of chronic levodopa treatment is dyskinesia, the difficulty or …